Transition from Acute to Chronic Pelvic Pain in a Murine Model of Chronic Prostatitis
Project Number7K01DK114395-04
Former Number5K01DK114395-03
Contact PI/Project LeaderROMAN, KENNY M
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
Project Summary/Abstract:
The mentee of the application, Dr. Kenny Roman, is a Kirschstein-NRSA postdoctoral fellow in the
Department of Urology at Northwestern University. During the award period, Dr. Roman will be provided with
laboratory space, animal housing facilities, core labs, equipment, networking opportunities, and crucial
mentorship from accomplished faculty to successfully complete the proposed project. Also, the Department of
Urology is committed and invested in the future career of Dr. Roman and has offered him a full-time research-
track faculty position. Dr. Roman's long term career goals are to 1) to increase his productivity and quality of
published basic research, 2) obtain a tenured-track faculty position, and 3) generate significant preliminary data
to apply for a competitive RO1 grant. To achieve these goals, Dr. Roman has proposed a career development
plan that's designed to provide a balance of mentorship and freedom to help him achieve research independence
and self-efficacy. Specifically, the career development plan includes courses to strengthen his knowledge in the
field of neuroscience, teach mentorship, and promote his grantsmanship skills. Dr. Roman's mentor (Dr. Praveen
Thumbikat) and co-mentors (Dr. Kevin E. McKenna and Dr. Anthony J. Schaeffer) are highly committed to his
success and strongly believe in Dr. Roman's potential to establish an independent research program, attain the
expertise to obtain R01 funds, and manage a successful academic career.
The proposed project will establish a link between activation of the mTOR pathway and changes to
neurobiological and neuroinflammatory systems in relevant cortices during the transition from acute to chronic
pelvic pain in an autoimmune mouse model of CP/CPPS called experimental autoimmune prostatitis (EAP).
Recent studies published by the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) research
network showed that the insular cortex is impaired in patients with CP/CPPS. Moreover, preliminary data from
the mentee's laboratory suggests the phosphorylation of S6K, a downstream mTOR pathway signaling kinase,
is elevated in the prelimbic cortex (interconnected to the insula) of mice with EAP. However, the intracellular
signaling mechanisms and cell types that influence changes in specific cortices during the transition from acute
to chronic pelvic pain have not been fully explored. Therefore, the long term goal of this project is to identify the
mTOR pathway as a signaling mechanism that mediates the transition from acute to chronic pelvic in brain
cortices due to neuro-glia interactions in mice with EAP. Overall, the mentee seeks to 1) determine the transition
from acute to chronic pelvic pain in mice with EAP, 2) establish the role of the mTOR pathway in driving the
transition from acute to chronic pelvic pain in insular and prelimbic cortices, and 3) explore the contribution of
neuroinflammation during the transition from acute to chronic pelvic pain in the insular and prelimbic cortices.
Successful completion of the research aims will lead to improved treatment options and expand our
understanding of the mechanisms that initiate and maintain symptoms associated with CP/CPPS.
Public Health Relevance Statement
Project Narrative:
Patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) develop debilitating chronic
suprapubic pain that impacts the quality-of-life. The proposed project will investigate the mechanistic role of the
mTOR pathway in brain cortices during the transition from acute to chronic pelvic pain in a mouse model of
CP/CPPS. Thus, the main goal of the proposed project is to expand our understanding of chronic pelvic pain
pathogenesis and identify new therapeutic targets in overlooked regions of the brain that are relevant to
CP/CPPS.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
11-July-2018
Project End Date
30-June-2023
Budget Start Date
18-May-2021
Budget End Date
30-June-2021
Project Funding Information for 2020
Total Funding
$38,117
Direct Costs
$35,068
Indirect Costs
$3,049
Year
Funding IC
FY Total Cost by IC
2020
National Institute of Diabetes and Digestive and Kidney Diseases
$38,117
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7K01DK114395-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7K01DK114395-04
Patents
No Patents information available for 7K01DK114395-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7K01DK114395-04
Clinical Studies
No Clinical Studies information available for 7K01DK114395-04
News and More
Related News Releases
No news release information available for 7K01DK114395-04
History
No Historical information available for 7K01DK114395-04
Similar Projects
No Similar Projects information available for 7K01DK114395-04